A new biomarker of breast cancer stage and patient response to neoadjuvant chemotherapy: HLA-DR expression in cytotoxic and regulatory T cells

D. P. Saraiva; A. Jacinto; S. Braga; M. G. Cabral

A new biomarker of breast cancer stage and patient response to neoadjuvant chemotherapy: HLA-DR expression in cytotoxic and regulatory T cells

D. P. Saraiva, A. Jacinto, S. Braga, M. G. Cabral

NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)
Centro de Estudos de Doenças Crónicas (CEDOC)

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Journal	Annals of Oncology
Volume	29
Publication status	Published - Oct 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{59674ef4b36e47c5816de77bc10cae71,

title = "A new biomarker of breast cancer stage and patient response to neoadjuvant chemotherapy: HLA-DR expression in cytotoxic and regulatory T cells",

author = "Saraiva, {D. P.} and A. Jacinto and S. Braga and Cabral, {M. G.}",

year = "2018",

month = oct,

language = "English",

volume = "29",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "European Society for Medical Oncology | Elsevier",

}